FY2028 Earnings Forecast for Scholar Rock Issued By Wedbush

Scholar Rock Holding Co. (NASDAQ:SRRK - Free Report) - Wedbush upped their FY2028 EPS estimates for shares of Scholar Rock in a research note issued on Tuesday, November 12th. Wedbush analyst D. Nierengarten now expects that the company will earn $0.39 per share for the year, up from their prior estimate of $0.33. Wedbush has a "Outperform" rating and a $37.00 price objective on the stock. The consensus estimate for Scholar Rock's current full-year earnings is ($2.37) per share.

Several other equities research analysts also recently commented on the company. JPMorgan Chase & Co. upped their target price on Scholar Rock from $18.00 to $31.00 and gave the company an "overweight" rating in a report on Monday, October 14th. Piper Sandler upped their price objective on shares of Scholar Rock from $28.00 to $42.00 and gave the company an "overweight" rating in a research note on Tuesday, October 15th. HC Wainwright raised their target price on shares of Scholar Rock from $35.00 to $40.00 and gave the stock a "buy" rating in a report on Tuesday. Finally, BMO Capital Markets boosted their price target on shares of Scholar Rock from $34.00 to $38.00 and gave the company an "outperform" rating in a report on Friday, October 11th. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Scholar Rock has an average rating of "Buy" and an average price target of $34.00.

Scholar Rock Price Performance

Shares of NASDAQ SRRK traded up $0.12 during trading on Thursday, hitting $27.50. The company had a trading volume of 883,812 shares, compared to its average volume of 1,134,421. The company has a market cap of $2.20 billion, a P/E ratio of -11.65 and a beta of 0.47. The company has a debt-to-equity ratio of 0.36, a quick ratio of 6.04 and a current ratio of 6.04. The business's 50-day moving average is $19.86 and its 200 day moving average is $13.43. Scholar Rock has a 52 week low of $6.76 and a 52 week high of $35.38.

Hedge Funds Weigh In On Scholar Rock

Several institutional investors have recently bought and sold shares of the stock. FMR LLC increased its holdings in shares of Scholar Rock by 3.1% during the 3rd quarter. FMR LLC now owns 10,196,046 shares of the company's stock valued at $81,670,000 after acquiring an additional 308,813 shares during the last quarter. Redmile Group LLC raised its position in shares of Scholar Rock by 0.3% in the first quarter. Redmile Group LLC now owns 6,419,610 shares of the company's stock valued at $114,012,000 after purchasing an additional 17,105 shares during the period. Vanguard Group Inc. lifted its stake in shares of Scholar Rock by 4.0% in the first quarter. Vanguard Group Inc. now owns 2,969,534 shares of the company's stock worth $52,739,000 after buying an additional 114,550 shares during the last quarter. Millennium Management LLC boosted its holdings in shares of Scholar Rock by 159.2% during the 2nd quarter. Millennium Management LLC now owns 925,584 shares of the company's stock worth $7,710,000 after buying an additional 568,512 shares during the period. Finally, Hood River Capital Management LLC raised its holdings in Scholar Rock by 5.1% in the 2nd quarter. Hood River Capital Management LLC now owns 832,792 shares of the company's stock worth $6,937,000 after acquiring an additional 40,745 shares during the period. 91.08% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CFO Edward H. Myles sold 206,240 shares of the stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $26.56, for a total value of $5,477,734.40. Following the transaction, the chief financial officer now owns 161,088 shares in the company, valued at approximately $4,278,497.28. This represents a 56.15 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Srinivas Akkaraju sold 1,175,713 shares of Scholar Rock stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $29.25, for a total transaction of $34,389,605.25. Following the completion of the sale, the director now owns 5,612,896 shares of the company's stock, valued at $164,177,208. This trade represents a 17.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,415,340 shares of company stock worth $40,666,088 in the last quarter. 19.20% of the stock is currently owned by corporate insiders.

About Scholar Rock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.